Vimpat®

Active substance

lacosamide

Holder

UCB Pharma SA

Status

Closed

Indication

Adjuvant therapy in the treatment of partial seizures with or without secondary

generalization in adults, adolescents and children from 4 years old with epilepsy

Public documents

Approbation

Information for the patient

Informed consent

Last update

10/08/2022

Last updated on 13/02/2024